Skip to content
10-Q/A

Quarterly Report

Lazuriton Nano Biotechnology (U.S.A.) Inc.

0001640334-18-001910

← back to feed
Filed
Oct 12, 2018 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2018 · Oct 9, 2018 110.92M sh
Operating Cash Flow Q2 2018 · Jun 30, 2018 $2
Operating Cash Flow Q2 2018 · Jun 30, 2017 −$299.74K
Cash And Equivalents restated Q2 2018 · Jun 30, 2018 $1.2K
Cash And Equivalents Q2 2018 · Dec 31, 2017 $1.19K
Cash And Equivalents Q2 2018 · Jun 30, 2017 $1.19K
Cash And Equivalents Q2 2018 · Dec 31, 2016 $100.93K
Stockholders Equity Q2 2018 · Jun 30, 2018 −$152.47K
Stockholders Equity Q2 2018 · Dec 31, 2017 −$104.24K
Current Liabilities Q2 2018 · Jun 30, 2018 $153.67K
Current Liabilities Q2 2018 · Dec 31, 2017 $105.43K
Total Liabilities Q2 2018 · Jun 30, 2018 $153.67K
Total Liabilities Q2 2018 · Dec 31, 2017 $105.43K
Current Assets Q2 2018 · Jun 30, 2018 $1.2K
Current Assets Q2 2018 · Dec 31, 2017 $1.19K
Total Assets Q2 2018 · Jun 30, 2018 $1.2K
Total Assets Q2 2018 · Dec 31, 2017 $1.19K
Sga Expense Q2 2018 · Jun 30, 2018 $18.29K
Sga Expense Q2 2018 · Jun 30, 2018 $48.23K
Sga Expense Q2 2018 · Jun 30, 2017 $18.9K
Sga Expense Q2 2018 · Jun 30, 2017 $138.51K
Net Income Q2 2018 · Jun 30, 2018 −$18.29K
Net Income Q2 2018 · Jun 30, 2018 −$48.23K
Net Income Q2 2018 · Jun 30, 2017 −$18.89K
Net Income Q2 2018 · Jun 30, 2017 −$138.5K
Operating Income Q2 2018 · Jun 30, 2018 −$18.29K
Operating Income Q2 2018 · Jun 30, 2018 −$48.23K
Operating Income Q2 2018 · Jun 30, 2017 −$18.9K
Operating Income Q2 2018 · Jun 30, 2017 −$138.51K